— Know what they know.
Not Investment Advice

028300.KQ

HLB Co., Ltd.
1W: +1.2% 1M: -2.3% 3M: +2.4% YTD: -2.9% 1Y: -33.3% 3Y: +69.2% 5Y: +23.4%
₩51,300.00 ($33.96)
+200.00 (+0.39%)
 
Weekly Expected Move ±11.7%
₩40776 ₩47038 ₩53300 ₩59562 ₩65824
KOE · Healthcare · Biotechnology · ₩6.70T · Alpha Radar Buy · Power 53
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap₩6.70T ($4.4B)
52W Range36150-69200
Volume336,216
Avg Volume1,014,650
Beta0.41
Dividend
Analyst Ratings
No analyst coverage
Company Info
CEOYoon Ki Baek
Employees160
SectorHealthcare
IndustryBiotechnology
IPO Date2008-12-24
216-53, Dangwol-ro
Ulsan 135-816
KR
82 5 2240 3500
About HLB Co., Ltd.

HLB Co., Ltd. manufactures pharmaceutical products, and builds ships. It manufactures and sells various types of lifeboats for marine plants, drill ships, and cruise vessels in South Korea. The company offers conventional type lifeboats, free fall type lifeboats, and rescue boats. It also provides marine and yacht engines; hooks; RIB, patrol, fishing, aluminum, and leisure boats; fishery inspection ships; and safety goods, as well as lifeboat and davit inspection and repair services, service engineering training, and spare parts for lifeboats and davits. In addition, the company develops Riboseranib, a targeted anti-cancer agent; and Apilia that is used for the treatment for ovarian cancer. HLB Co., Ltd. was founded in 1975 and is headquartered in Ulsan, South Korea.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms